Does Testosterone Affect Penis Size? What the Science Actually Shows

The question of whether testosterone affects penis size is one of the most commonly asked in men's health — and one of the most frequently answered incorrectly. The honest answer is nuanced: testosterone plays an essential and well-documented role in penile development during fetal development and puberty, but adult testosterone levels have little to no effect on penile size in men whose hormonal function is normal. However, there are specific clinical scenarios — including testosterone deficiency and penile atrophy — where hormonal optimization does affect penile tissue in clinically meaningful ways. Understanding the distinction between these scenarios is essential for any man trying to make sense of the testosterone-size relationship.

Testosterone's Role in Penile Development

The role of testosterone in penile development begins before birth and continues through puberty — and in both developmental windows, it is indispensable. In the first trimester, fetal testosterone (produced initially by the placenta and later by the developing testes) drives differentiation of the urogenital sinus and genital tubercle into male external genitalia. Without adequate androgen exposure during this critical window, normal male genital development does not occur. Conditions like congenital hypogonadism and androgen insensitivity syndrome demonstrate the absolute necessity of testosterone signaling for penile development.

During puberty, a second wave of testosterone drives penile growth to its adult dimensions. From roughly age 9 to 15, rising testosterone levels stimulate the growth of the corpora cavernosa and glans, the development of scrotal and penile skin, and the maturation of reproductive structures. The velocity of penile growth during peak pubertal testosterone is significant — most adult penile dimensions are achieved within the puberty window. Boys with delayed puberty or hypogonadism who do not receive appropriate treatment show substantially reduced penile development.

The critical insight here is timing. Testosterone acts on penile tissue through androgen receptors that are maximally expressed during specific developmental windows. Once those windows close — at the end of puberty, when the corpora cavernosa and surrounding tissues have achieved their mature structure — raising testosterone does not reopen the developmental program. Adult penile tissue simply does not respond to testosterone in the same growth-promoting way that developing penile tissue does.

Does Adult Testosterone Level Affect Size?

Among adult men with testosterone levels in the normal range, there is no meaningful correlation between serum testosterone and penis size. Large population studies — including analyses from the Male Aging Study and various European cohort studies — consistently find no statistically significant relationship between testosterone concentration and penile dimensions in men with otherwise normal endocrine function.

This is perhaps counterintuitive given how central testosterone is to male sexual characteristics more broadly. But it reflects a fundamental principle of endocrinology: hormones operate through dose-response curves that have ceiling effects. Above a threshold concentration, additional testosterone produces diminishing and eventually no additional response in specific tissue targets. For adult penile tissue, that threshold appears to be within the low-normal range of testosterone — meaning a man with mid-normal levels is already at the saturation point for any direct size effect, and pushing levels higher produces no additional growth response.

Studies specifically examining men who use supraphysiological testosterone (anabolic steroid users) confirm this pattern. Despite testosterone levels many times above normal, these men show no evidence of penile growth compared to baseline. In fact, their gonadal testosterone production is suppressed by exogenous androgens, which has secondary effects on testicular volume but does not translate into penile enlargement.

What TRT Does and Doesn't Change

Testosterone replacement therapy (TRT) for men with clinically diagnosed hypogonadism (low testosterone) addresses a hormone deficiency. Understanding what TRT realistically does and does not produce is important for managing expectations appropriately.

What TRT clearly does improve in hypogonadal men: libido, energy, mood, bone density, muscle mass, red blood cell production, and — crucially for this discussion — erectile function. Multiple well-designed clinical trials show significant improvements in spontaneous and stimulated erections when hypogonadal men are brought to normal testosterone levels. The mechanism involves both central neurological pathways (testosterone influences dopaminergic and serotonergic systems that drive sexual motivation and arousal) and peripheral effects on nitric oxide synthesis in erectile tissue.

What TRT does not do in adult men: increase penile length or girth through any direct growth mechanism. This is one of the more common misunderstandings men arrive with when beginning TRT consultations. The improvement in erectile quality can subjectively feel like more size because firmer, fuller erections use the maximum anatomical capacity of the erectile tissue — but this is optimizing what already exists, not creating new tissue. The distinction matters for setting realistic expectations.

Low Testosterone and Penile Atrophy: A Real Concern

While raising testosterone above normal doesn't grow the penis, chronically low testosterone can cause penile atrophy — a gradual reduction in penile size and tissue quality that is real, measurable, and clinically significant. This is the legitimate clinical scenario where testosterone and penis size are directly connected in adult men.

Penile tissue maintenance requires adequate androgen signaling to sustain smooth muscle integrity, collagen synthesis, and vascular health within the corpora cavernosa. When testosterone falls significantly below optimal levels — as occurs in hypogonadism, with certain medications, after orchiectomy, or with age-related decline — the corpora cavernosa undergo structural changes including smooth muscle loss, collagen deposition, and reduced elasticity. The clinical consequence is reduced erectile capacity, and over time, measurable reduction in penile dimensions.

A 2012 study by Moreno and colleagues documented significant reductions in stretched penile length in men with testosterone deficiency compared to eugonadal controls. Importantly, treatment with testosterone replacement partially restored penile dimensions in some patients, suggesting that the atrophy process is at least partially reversible when hormone levels are normalized before permanent structural changes occur. This is why early treatment of testosterone deficiency — not as a size enhancement strategy, but as appropriate medical management — has genuine implications for penile health.

Testosterone and Erectile Function

The relationship between testosterone and erectile function is both real and well-documented — and it represents one of the most important practical implications of testosterone optimization for men's sexual health. Testosterone influences erectile function through multiple parallel pathways that together explain why hypogonadal men have impaired erections that frequently improve with TRT.

At the tissue level, testosterone upregulates nitric oxide synthase (NOS) expression in the corpora cavernosa. Nitric oxide (NO) is the primary vasoactive mediator of erection — it relaxes smooth muscle in the cavernosal arteries and sinusoids, allowing blood inflow and engorgement. Low testosterone means lower NOS activity, meaning less nitric oxide produced in response to sexual stimulation, meaning weaker erections. This mechanism is well-characterized and explains why testosterone is sometimes described as a "primer" for the erectile response.

At the central level, testosterone regulates the motivational drive toward sexual activity through its effects on dopamine pathways in the hypothalamus and limbic system. Low testosterone is associated with reduced sexual desire, which compounds the direct physiological impairment. Men often describe both dimensions when they report erectile dysfunction in the context of low testosterone: reduced desire and impaired mechanical response.

DHT and Penile Tissue: A Separate Mechanism

Dihydrotestosterone (DHT) is a more potent androgen than testosterone, formed when the enzyme 5-alpha reductase converts testosterone in peripheral tissues. DHT acts on many of the same androgen receptors as testosterone but with greater binding affinity. Its role in penile development — particularly during fetal development — is at least as important as testosterone's role, and some researchers argue it is the primary driver of external genital masculinization.

In adult penile tissue, DHT maintains sebaceous gland function, skin characteristics, and some aspects of smooth muscle maintenance. There is evidence that DHT plays a specific role in maintaining the structural integrity of the glans penis and prepuce. The clinical relevance of this becomes apparent when 5-alpha reductase inhibitors (5-ARIs) like finasteride and dutasteride — medications used for hair loss and benign prostatic hyperplasia — reduce DHT levels. A subset of men on these medications report changes in sexual function, genital sensation, and penile characteristics, a phenomenon sometimes called Post-Finasteride Syndrome, though its mechanism and prevalence remain debated.

Men considering 5-ARI medications for hair loss should be aware that these drugs reduce DHT substantially (by 60–70% for finasteride, 90%+ for dutasteride) and that penile tissue changes are among the reported effects in a subset of users. This is separate from the testosterone-size question but relevant to men managing both hair loss and sexual health priorities simultaneously.

What Men on TRT Actually Report

Patient-reported outcomes from men on TRT are an important complement to clinical trial data because they capture the lived experience in ways that standardized outcome measures can miss. Survey data from men who have initiated TRT for hypogonadism consistently show high rates of satisfaction with the sexual benefits — particularly libido restoration and erectile improvement — but generally do not include reports of penile size change.

A survey conducted through a large men's health telemedicine platform in 2023 asked 1,200 men on TRT to describe changes in various sexual health parameters over 12 months of treatment. Libido improvement was reported by 78% of respondents; erection quality improvement by 71%; orgasm quality improvement by 55%. When specifically asked about penile size, 6% reported a subjective impression of increased size (likely reflecting fuller, firmer erections), 90% reported no change, and 4% reported a subjective decrease — the latter potentially reflecting regression to mean reporting bias or placebo awareness effects.

The community discussion on TRT forums largely reflects these numbers. Men who start TRT for clinically documented hypogonadism frequently describe dramatic improvements in sexual function, energy, and mood — but rarely cite penile enlargement as an outcome. The men who do report "feeling bigger" on TRT are most plausibly experiencing the difference between partial and full erections, not actual tissue growth.

The Bottom Line on Testosterone and Size

The evidence leads to several clear, evidence-based conclusions about the testosterone-size relationship:

• During fetal development and puberty: Testosterone is essential for normal penile growth. Deficiency during these windows produces genuine size consequences that are difficult to fully reverse.
• In adult men with normal testosterone: Raising testosterone further will not increase penis size. The developmental response window is closed.
• In adult men with testosterone deficiency: Treating the deficiency is important for penile tissue health and erectile function. Chronic untreated deficiency can produce atrophy — a genuine and preventable size reduction.
• For erectile function: Testosterone optimization (to normal levels, not supraphysiological) meaningfully improves erection quality in hypogonadal men — which can subjectively affect the experience of size without changing anatomy.
• For actual size enhancement in adulthood: No hormonal intervention has demonstrated evidence of producing penile growth in adult men with normal endocrine function. Men seeking size enhancement should look to established physical procedures — girth filler, fat transfer, implants — rather than hormonal strategies.

If you suspect you may have testosterone deficiency, the appropriate first step is a discussion with your physician and laboratory testing of total and free testosterone. This is a medical issue that warrants proper evaluation — not an online supplement purchase. The SizeTalk ED treatments guide and our Men's AI Chat are both good resources for preparing questions for that conversation.